Surgical treatment of an isolated omental cervical cancer recurrence: report of a case and review of the literature

Tumori. 2014 Mar-Apr;100(2):e52-4. doi: 10.1177/030089161410000225.

Abstract

Aims and background: Recurrent cervical cancer has traditionally been associated with a dismal prognosis. Historically, patients who developed distant metastases from cervical cancer were not considered eligible for surgical resection; only palliative treatment options are available, generally consisting of chemo- and/or radiotherapy. Metastases usually appear in the liver, lung or lymph nodes. The abdominal cavity is a quite unusual site of recurrence and the disease usually has multiple foci. For this reason, peritoneal involvement by cervical cancer is considered a contraindication to local treatment.

Methods and study design: We report the first case of a 30-year-old woman with isolated intra-abdominal cervical cancer recurrence diagnosed with 18F-FDG PET/CT, successfully surgically treated.

Results: Histopathological analysis confirmed the tumor to be an omental relapse of squamous cervical cancer previously treated with anterior pelvic exenteration and platinum based chemotherapy. The patient underwent adjuvant treatment with 3 cycles of topotecan and has remained free of disease during the 4 years of follow-up.

Conclusions: In selected cases with isolated recurrences, a surgical resection may provide a long term complete remission in recurrent cervical cancer patients.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Carcinoma, Squamous Cell / diagnostic imaging
  • Carcinoma, Squamous Cell / secondary*
  • Carcinoma, Squamous Cell / surgery*
  • Chemotherapy, Adjuvant
  • Contrast Media
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Recurrence, Local / surgery*
  • Omentum* / diagnostic imaging
  • Omentum* / pathology
  • Omentum* / surgery
  • Peritoneal Neoplasms / diagnostic imaging
  • Peritoneal Neoplasms / secondary*
  • Peritoneal Neoplasms / surgery*
  • Positron-Emission Tomography / methods
  • Tomography, X-Ray Computed
  • Topoisomerase I Inhibitors / therapeutic use
  • Topotecan / therapeutic use
  • Treatment Outcome
  • Uterine Cervical Neoplasms / pathology*

Substances

  • Contrast Media
  • Topoisomerase I Inhibitors
  • Fluorodeoxyglucose F18
  • Topotecan